Project ALS is pleased to share that the FDA has approved the drug edaravone – the first approved ALS treatment in over 20 years.
Edaravone, a free radical scavenger, appears to react with nerve-damaging compounds generated as part of the disease process. After six months of treatment, on top of standard-of-care, data showed the intravenous drug reduced the rate of functional decline in patients by about a third.
Read more
Stories of the Season: Sue, Martha & Rob
The Family That Jenifer Built There are families formed by blood, and there are families formed by shared purpose. Project ALS was built by the
December 23, 2025
No Comments
